Capricor Therapeutics | CAPR - Capital Ordinário





Capital Ordinário Alterar Data
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Bioline Rx USD 2.61B 0 2025-12
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cipla INR 807.78M 17K 2026-03
Cytokinetics USD 124.43M 2.17M 2026-03
Geron USD 640.9M 2.54M 2026-03
Grifols EUR 680.58M 846.11K 2025-12
Immunic USD 120.38M 21.73M 2025-12
J&J USD 2.41B 1.35M 2026-03
Plus Therapeutics USD 275K 138.4M 2026-03
Prothena USD 53.08M 756K 2026-03
PTC Therapeutics USD 82.88M 1.41M 2026-03
Sarepta Therapeutics USD 105.62M 53K 2026-06